Abstract
Historical clinical trial data may supplement a control arm of a randomised clinical trial to achieve more patient-centric, cost-effective, and accelerated clinical development. The hybrid control design may preserve the benefits of randomisation while also strengthening trial evidence by integrating historical data with an evaluation of consistency between concurrent and historical trial data. However, few examples have been established to assess the applicability of such design in supporting early trial development.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
